| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 32,350 | 27,042 | 24,075 | | Cost of Revenue | 1,263 | 1,193 | 1,129 | | | Gross Profit | 31,087 | 25,849 | 22,946 | | | Operating Expenses | | Research Development | 2,986 | 2,755 | 2,426 | | Selling General and Administrative | 12,915 | 11,337 | 10,565 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 15,186 | 11,757 | 9,955 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 44 | 82 | | Earnings Before Interest And Taxes | 15,197 | 11,801 | 10,037 | | Interest Expense | 668 | 1,540 | 1,451 | | Income Before Tax | 14,529 | 10,261 | 8,586 | | Income Tax Expense | 4,374 | 3,443 | 2,598 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,155 | 6,818 | 5,988 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 10,155 | 6,818 | 5,988 | | Preferred Stock And Other Adjustments |
-
| 2,930 | (2,930) | | | Net Income Applicable To Common Shares | $10,155 | $9,748 | $3,058 |
|
0.08% Nasdaq 
0.08%
Income Statement
